SOX2 and ovarian cancer: Bellio et al. observed an increase in SOX2 and POU5F1 (encoding OCT4) mRNA levels, an enrichment of ALDH-, CD133-, and CD117-positive cells, and a significant increase in sphere-forming capacity following PARPi treatment of ovarian cancer cell lines [24].